-+ 0.00%
-+ 0.00%
-+ 0.00%

B of A Securities Initiates Coverage On Eikon Therapeutics with Buy Rating, Announces Price Target of $34

Benzinga·03/02/2026 11:46:42
Listen to the news
B of A Securities analyst Jason Zemansky initiates coverage on Eikon Therapeutics (NASDAQ:EIKN) with a Buy rating and announces Price Target of $34.